UNICA IRIS Institutional Research Information System

LA NASA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 290.158
NA - Nord America 28.751
AS - Asia 11.901
SA - Sud America 2.006
Continente sconosciuto - Info sul continente non disponibili 1.100
AF - Africa 337
OC - Oceania 110
Totale 334.363
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 279.389
US - Stati Uniti d'America 28.114
SG - Singapore 4.414
CN - Cina 3.924
NL - Olanda 3.336
UA - Ucraina 1.856
BR - Brasile 1.546
SE - Svezia 1.540
VN - Vietnam 1.045
FI - Finlandia 912
DE - Germania 884
GB - Regno Unito 780
FR - Francia 661
HK - Hong Kong 481
IN - India 404
CA - Canada 377
KR - Corea 320
BD - Bangladesh 189
JP - Giappone 170
AR - Argentina 158
IQ - Iraq 143
TR - Turchia 119
MX - Messico 115
PL - Polonia 113
RU - Federazione Russa 110
IE - Irlanda 100
ZA - Sudafrica 99
AU - Australia 96
PK - Pakistan 89
AT - Austria 87
ES - Italia 79
EC - Ecuador 73
IR - Iran 70
ID - Indonesia 69
SA - Arabia Saudita 62
CO - Colombia 58
MY - Malesia 52
MA - Marocco 50
VE - Venezuela 49
EG - Egitto 48
UZ - Uzbekistan 45
PH - Filippine 44
BE - Belgio 39
CL - Cile 36
JM - Giamaica 36
CZ - Repubblica Ceca 33
LT - Lituania 33
RO - Romania 33
IL - Israele 32
CH - Svizzera 30
JO - Giordania 26
PY - Paraguay 26
AE - Emirati Arabi Uniti 24
ET - Etiopia 23
DK - Danimarca 22
TH - Thailandia 22
CR - Costa Rica 21
KE - Kenya 20
KZ - Kazakistan 20
PE - Perù 20
NP - Nepal 18
TW - Taiwan 18
TN - Tunisia 17
UY - Uruguay 17
AZ - Azerbaigian 15
PT - Portogallo 15
HN - Honduras 14
OM - Oman 14
DZ - Algeria 13
HU - Ungheria 13
MU - Mauritius 13
BO - Bolivia 12
GT - Guatemala 12
NZ - Nuova Zelanda 12
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
IS - Islanda 10
LB - Libano 10
GE - Georgia 9
PA - Panama 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
TT - Trinidad e Tobago 9
EU - Europa 8
GR - Grecia 8
NG - Nigeria 8
NI - Nicaragua 8
SD - Sudan 8
AL - Albania 7
BG - Bulgaria 7
BY - Bielorussia 7
NO - Norvegia 7
PR - Porto Rico 7
TZ - Tanzania 7
GY - Guiana 6
JE - Jersey 6
RS - Serbia 6
SN - Senegal 6
AM - Armenia 5
AO - Angola 5
Totale 333.171
Salva come PNG Salva come JPEG
Città #
Cagliari 269.118
Uta 7.753
Ashburn 3.904
Amsterdam 3.199
Singapore 2.132
Fairfield 1.950
San Jose 1.884
Woodbridge 1.625
Chandler 1.472
Boardman 1.270
Dallas 1.200
Houston 1.079
Ann Arbor 1.016
Jacksonville 956
Wilmington 858
Nyköping 847
Seattle 771
Beijing 723
Cambridge 669
New York 596
Helsinki 591
Council Bluffs 570
Los Angeles 558
Hong Kong 407
Hefei 406
Santa Clara 346
Lauterbourg 329
Nanjing 316
Boston 312
Ho Chi Minh City 303
Milan 287
The Dalles 268
Seoul 246
Dearborn 211
São Paulo 206
Hanoi 205
Munich 198
Buffalo 191
Shanghai 186
Rome 178
Dong Ket 150
San Diego 145
Toronto 145
Columbus 120
Chicago 115
Orem 108
Shenyang 103
Guangzhou 101
Tokyo 93
Atlanta 92
Changsha 90
Hebei 90
Frankfurt am Main 84
London 83
Nanchang 83
Tianjin 82
Redondo Beach 81
Verona 80
Nuremberg 78
Phoenix 74
Redwood City 73
Warsaw 72
Denver 71
Rio de Janeiro 70
Washington 68
Brooklyn 67
Montreal 66
Jiaxing 65
Orange 61
Baghdad 60
Dublin 60
Menlo Park 59
Pune 56
San Francisco 55
Mountain View 51
Norwalk 51
Vienna 51
Sassari 49
Chennai 48
Da Nang 46
Stockholm 41
Tashkent 41
Jinan 38
Mumbai 38
Sydney 38
Johannesburg 37
Brussels 36
Incheon 36
Manchester 35
Haiphong 34
North Bergen 33
Ningbo 32
Wuhan 32
Naples 31
Las Vegas 30
Istanbul 29
New Delhi 29
Ankara 28
Auburn Hills 28
Brasília 28
Totale 313.206
Salva come PNG Salva come JPEG
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.591
HLA-G expression and role in advanced-stage classical Hodgkin lymphoma 3.598
The impact of NOD2/CARD15 SNPs on the severe gastrointestinal GVHD following allogeneic Stem Cell Transplantation in Sardinia population 3.508
Comparison Between an Artificial Neural Network and Logistic Regression in Predicting Long Term Kidney Transplantation Outcome 3.451
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.440
Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma 3.383
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients 3.355
What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics 3.334
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.334
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients 3.334
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia 3.254
Reassessing the approach to informed consent: The case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 3.074
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.932
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia 2.897
Ruolo del trapianto allogenico nelle talassemie 2.840
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma 2.759
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.731
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 2.623
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 2.617
In vitro ovine articular chondrocyte proliferation: experiments and modelling 2.564
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes 2.540
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.274
Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells 2.272
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia 2.268
Health related quality of life in patients with onco-hematological diseases 2.260
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 2.207
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.180
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.140
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.132
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 2.129
Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma 2.067
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 2.013
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 2.000
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.983
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia 1.974
Ruxolitinib therapy and telomere length in myelofibrosis 1.969
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life 1.963
Experimental analysis and modeling of in vitro mesenchymal stem cells proliferation 1.949
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.931
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 1.884
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis 1.849
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors 1.847
THE HLA-G 14-BP POLYMORPHISM IS AN INDEPENDENT GENETIC RISK MARKER OF LONG-TERM KIDNEY TRANSPLANTATION OUTCOME 1.844
The human leukocyte antigen-g 14-bp polymorphism is an independent genetic risk marker of long-term kidney transplantation outcome 1.817
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.777
null 1.759
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting 1.703
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.632
Acute basophilic leukemia with U2AF1 mutation 1.605
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.597
Systemic Mastocytosis with Associated Primary Myelofibrosis 1.590
Unrelated bone marrow transplantation in Thalassemia. The experience of the Italian Bone Marrow transplant Group (GITMO) 1.568
T cell tyrosine phosphorylation response to transient redox stress 1.566
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 1.557
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 1.547
Erythroblast morphology in refractory anemia with ring sideroblasts and thrombocytosis 1.542
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.516
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.503
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report 1.485
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party 1.474
Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia 1.473
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 1.472
Perls stain grade in bone marrow aspirate correlates with overall survival in low-risk myelodysplastic patients 1.463
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation 1.461
Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors 1.454
Resolution of capillary leak syndrome by extracorporeal membrane oxygenation 1.423
null 1.419
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 1.412
Improved outcomes With retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 1.385
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation 1.377
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study 1.374
Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm 1.355
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia 1.353
Immunological deregulation in classic hodgkin lymphoma 1.337
A simulated case of chronic myeloid leukemia: the growing risk of Munchausen’s Syndrome by internet 1.331
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated donor hematopoietic stem cell transplantation in thalassemia patients 1.315
Rectal involvement in pre-early T acute lymphoblastic leukemia 1.314
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 1.305
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 1.289
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.276
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? 1.271
Immunohistochemical findings in the lungs of COVID-19 subjects: Evidence of surfactant dysregulation 1.252
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.249
Expression of l1 cell adhesion molecule (l1cam) in extracellular vesicles in the human spinal cord during development 1.246
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia 1.240
The role of inhibitory KIR 2DL5 in the outcome of autologous hematopoietic stem cell transplantation for multiple myeloma 1.235
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 1.232
Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial 1.230
Multiple myeloma treatment in real-world clinical practice: Results of a prospective, multinational, noninterventional study 1.218
White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy 1.216
Stem cell transplantation for congenital dyserythropoietic anemia. An analysis from the European society for blood and marrow transplantation 1.205
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation: a crystal ball to foresee the future? 1.187
Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 trial 1.178
Dasatinib first-line: multicentric Italian experience outside clinical trials 1.174
The human carotid atherosclerotic plaque: an observational review of histological scoring systems 1.146
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated haematopoietic stem cell transplantation 1.145
null 1.138
null 1.128
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity 1.126
Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? 1.114
Totale 190.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 493.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 493.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213.929 0 0 0 1.108 1.369 1.078 857 1.108 1.518 2.163 2.377 2.351
2022/202325.815 2.001 2.970 2.705 1.991 2.030 2.703 1.279 3.292 1.629 1.580 2.425 1.210
2023/202429.541 1.598 1.200 1.519 2.189 2.610 4.937 3.738 2.052 1.522 2.385 2.983 2.808
2024/202558.229 9.818 10.782 9.877 6.931 3.620 6.636 3.175 487 1.063 3.964 829 1.047
2025/202622.229 1.362 955 2.691 1.967 1.543 1.418 5.298 891 1.644 2.157 1.231 1.072
2026/20276.295 526 1.006 2.266 2.497 0 0 0 0 0 0 0 0
Totale 334.363